Filing Details
- Accession Number:
- 0001567619-22-012778
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-13 16:36:35
- Reporting Period:
- 2022-06-09
- Accepted Time:
- 2022-06-13 16:36:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1034842 | Rigel Pharmaceuticals Inc | RIGL | Pharmaceutical Preparations (2834) | 943248524 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190279 | R Raul Rodriguez | Rigel Pharmaceuticals, Inc. 1180 Veterans Blvd. South San Francisco CA 94080 | Ceo, President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-09 | 1,000,000 | $0.69 | 1,391,776 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions ranging from $0.67 to $0.70. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each such separate price.